🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Chewable Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

whole Tart Cherry powder
250 mg
0.5 mg
📊 Market median: 3.0mg (984 products) 📚 236 studies (Tier A: 2, B: 109)
This product: 0.5mg UL 10mg

Other Ingredients

Xylitol Maltodextrin Stearic Acid Silica Soy Polysaccharides Cellulose Gum Malic Acid natural Tart Cherry flavor Crospovidone modified Food Starch Magnesium Stearate Citric Acid Gum Arabic Triacetin Tartaric Acid

Label Claims — Verification

All Other
Structure/Function
All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 1 tablet 20 minutes before bedtime. Tablets should be chewed before swallowing. No water necessary.

⚠️ Warnings & Precautions

Warning: If you are under medical supervision or using any tranquilizers or sedatives, seek the advice of your healthcare professional prior to using. Consult your physician before using if you have an autoimmune condition or depressive disorder or are pregnant or lactating.

Do not take when operating machinery or driving a vehicle.

People with allergies to wheat, soy, or corn shall consult their healthcare professional prior to using this product.

Keep out of reach of children.

Contains: Wheat, soy

🧪 Formulation Notes

100% drgu-free sleep aid for occasional sleeplessness

CherryPURE with high ORAC

Contains: Wheat, soy

Additional Information

Store in a cool, dry place.

ITEM: 6931.94 F: 3003097 L: 2007902-15077

Product Details

UPC / SKU 0 47469 06931 5
DSLD Entry Date 2018-01-25
Product Type Other Combinations
Form Tablet or Pill
Brand Natrol
DSLD ID 77805
Data Updated 2026-04-11

Research Evidence

291 Research Sources
55 Avg Quality Score
129 Meta Analysis
93 Systematic Review
51 Rct
11 Clinical Trial
2 Other
2 Regulatory Source
1 Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021
View all evidence for Melatonin →

Compare Similar Products

View all Melatonin products →